In vitro, AONs targeting PAX3 have been shown to inhibit PAX3::FOXO1 expression and trigger apoptosis in a fusion-positive rhabdomyosarcoma cell line [178]. The gene discussed is PAX3; the disease is rhabdomyosarcoma.